Managing Partner
RC CapitalCheck size: RC Capital does not publish a standard check-size range on its current official website.
Daniel Fleming contributes to RC Capital's published strategy: Build high-potential healthcare companies that improve care delivery, patient experience and outcomes across devices, services and healthcare IT.
The firm's public strategy favors founders and companies closely aligned with Healthcare, Medical Devices, Healthcare Services at Growth Stage and Lower Middle Market stages. No separate personal preference is claimed without first-party evidence.
No person-specific pass list is public. Opportunities outside RC Capital's stated stages, sectors or geographic mandate are less likely to fit the published strategy.
Show clear fit with RC Capital's Growth Stage/Lower Middle Market mandate, explain the problem and defensibility, provide evidence of traction appropriate to the stage, and state the financing need and use of funds.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Daniel Fleming is Managing Partner at RC Capital, according to the firm's current official roster. This profile intentionally avoids adding unverified employment or education claims when the official source supplies only role information.